GLAUCOMA EYE DROPS MARKET ANALYSIS

Glaucoma Eye Drops Market, by Drug Type (Prostaglandin analogs, Beta blockers, Alpha agonists, Carbonic Anhydrase Inhibitors (CAIs), Combined Medications and Others (rho-kinase inhibitor, Cholinergic agonist), by Disease Indication (Angle-closure Glaucoma and Open-angle Glaucoma), By Distribution Channel (Hospital Pharmacy Retail Pharmacy and Online Pharmacy), by Composition (Preservative Free, BAK-Based and Non BAK-Based Preservatives), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), -

Published In : Jul 2023
Code : CMI3984
Pages :144
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Glaucoma Eye Drops Market - Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global glaucoma eye drops market over the forecast period. This is due to the increasing number of partnerships and campaigns launched to raise awareness about glaucoma in this region. For instance, on January 3, 2023, Bausch + Lom- an eye health products company based in Vaughan, Ontario, Canada, and Glaucoma Research Foundation- an organization dedicated to developing a cure for glaucoma through innovative research, collaboration, and education, partnered together to launch the Screen, Protect, Cure campaign in recognition of glaucoma awareness month. A new educational campaign aims to educate individuals who may be at risk for glaucoma and raise funding for glaucoma research.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa